A pilot study of N-methyl-D-aspartate (NMDA) antagonist in Parkinson's disease.

類似資料

• N-methyl-D-aspartate (NMDA) antagonists in Parkinson's disease.
  著者:: Kornhuber, J, 等
  出版事項: (1993)
• N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease
  著者:: Olivares, David, 等
  出版事項: (2012)
• Differential action of NMDA antagonists on cholinergic neurotoxicity produced by N-methyl-D-aspartate and quinolinic acid.
  著者:: Pawley, A. C., 等
  出版事項: (1996)
• Direct Inhibition of N-Methyl-D-Aspartate (NMDA)-Receptor Function by Antiglaucomatous β-Antagonists
  著者:: Tatsuo Nagata, 等
  出版事項: (2008-01-01)
• Pentamidine is an N-methyl-D-aspartate receptor antagonist and is neuroprotective in vitro
  著者:: Reynolds, IJ, 等
  出版事項: (1992)